Skip to main content
Caplight Logo









Zhongmou Therapeutics

Zhongmou Therapeutics

Private
WuhanHealthcare & Life Scienceshttps://zmtherapeutics.com/

Last Round

VC Round

Jul 1, 2025

Company Overview

Zhongmou Therapeutics is a biotechnology company that develops optogenetic and gene-based therapies for the treatment of severe retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyoptogenetic therapyretinal diseaseophthalmologyAAV vectoradeno-associated virusretinitis pigmentosamacular degenerationprotein engineeringbiotechvision restorationclinical-stage biotechmutation-agnostic therapygene medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zhongmou Therapeutics Comparables

Compare Zhongmou Therapeutics with similar companies based on industry and business-model similarity.

Zhongmou Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Restore Vision Inc.
89%
Nanoscope Therapeutics Inc.
87%
SparingVision
87%

Zhongmou Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2025

Key People

Founding team and executive leadership

Yang Wu

Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2025

    Completed a VC Round fundraise.

Zhongmou Therapeutics Filings

Explore SEC and related filing metadata, where available.

Zhongmou Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zhongmou Therapeutics's valuation, stock price, and market status.

Is Zhongmou Therapeutics a public or private company?

Zhongmou Therapeutics is a private company.

What is the current stock price of Zhongmou Therapeutics?

Zhongmou Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Zhongmou Therapeutics worth (valuation)?

Valuation information for Zhongmou Therapeutics is not publicly available.

Can I buy Zhongmou Therapeutics stock?

Zhongmou Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zhongmou Therapeutics's last funding round?

Zhongmou Therapeutics's most recent funding round was VC Round on July 1, 2025.

Who are the main investors in Zhongmou Therapeutics?

Investor information for Zhongmou Therapeutics is not publicly disclosed.

Will Zhongmou Therapeutics IPO soon?

No public IPO plans have been announced for Zhongmou Therapeutics.

How can I track Zhongmou Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zhongmou Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWuhan
Employee Range11
Year Founded2019
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?